Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @CellectarBio
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @CellectarBio
-
$CLRB#DYK: According to@LLSusa, new cases of#leukemia,#lymphoma and#myeloma are expected to account for 10% of the estimated 1,762,450 new#cancer cases diagnosed in the U.S. in 2019. For more info, visit http://lls.org pic.twitter.com/bV0nksaja5
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
$CLRB Do you know some of the key signs and symptoms of having cancer? Check out the infographic below or visit http://worldcancerday.org for more information.#WorldCancerDay
#IAmAndIWill
pic.twitter.com/qMu3aF98dJ
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
$CLRB#DYK More than one third of cancer cases can be prevented and another third can be cured if detected early and treated properly.#WorldCancerDay
#IamAndIWill
http://worldcancerday.org pic.twitter.com/YpWVtJ8crjHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
The answer is ~32,270! Thank you to everyone who voted!
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
$CLRB According to@AmericanCancer, how many new cases of Multiple Myeloma will be diagnosed in the United States in 2020? For more information about Multiple Myeloma and other cancer types, visit http://cancer.org#mmsm#FridayMotivationPrikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
$CLRB Do you have our upcoming clinical data call on your calendar yet? If not, click the link for more information about the call: http://bit.ly/2u1gRLH For more info about#CLR131, visit http://bit.ly/31hOPIt#mmsm#ThursdayThoughtspic.twitter.com/Yu7E4yDsY6
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
$CLRB From the@cure_magazine interview with Dr. Laura Finn: “What I like about this drug, and especially in multiple myeloma, is its safety and its very low incidence of side effects.” http://bit.ly/2pA4WCK#CLR131#ClinicalTrials#mmsmpic.twitter.com/nCJiOvvG6h
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
$CLRB#ICYMI: Cellectar Biosciences to Host a#CLR131 Clinical Data Call with Its Phase 2 Lead Investigator on February 19, 2020 http://bit.ly/2R4I5bW#mmsm#clinicaltrialspic.twitter.com/NsOj9ro9LJHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
$CLRB “...drop the payload internally, inside of the cell. It’s the ultimate Trojan Horse, if you will, when you think about our delivery platform.” http://bit.ly/30fUIoX#mmsm#CLR131#WednesdayWisdompic.twitter.com/pdeQicRKX4Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
$CLRB Incredible article from@TIME “This is the first time [an increase in leukemia] has been shown to be statistically significant.” http://bit.ly/2G7CVae pic.twitter.com/P2LsYFUM0Z
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
$CLRB Check out our updated deck (http://bit.ly/2QP1TRT ) and put our upcoming clinical data call (http://bit.ly/2u1gRLH ) on your calendars!#mmsm#clinicaltrialspic.twitter.com/E2jjRpnyxL
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Thanks for following us
@MyelomaAmarc!#mmsmHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
$CLRB For more information about Cellectar visit: http://cellectar.com For articles about#CLR131, click the following: http://bit.ly/2oWHGhI l http://bit.ly/2Bh2283#myeloma#mmsm#ClinicalTrialsSaveLivespic.twitter.com/v53yoRHlQr
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
#ICYMI: Cellectar Receives Orphan Drug Designation for#CLR131 in Lymphoplasmacytic Lymphoma (LPL): http://bit.ly/2QtXgwv For more information about LPL, visit@LLSusa: http://bit.ly/2R6lDRf#FridayFactpic.twitter.com/OKpX7PC3tW
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
$CLRB Are you at#BiotechShowcase or#JPM20 today? We would love to connect! Check out our updated deck (http://bit.ly/2QP1TRT ) and put our upcoming clinical data call (http://bit.ly/2u1gRLH ) on your calendars!#mmsm#clinicaltrials#JPMWeekpic.twitter.com/RdEdeTcmI9
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
$CLRB#ICYMI: CEO Jim Caruso presented yesterday afternoon at Biotech Showcase to give an update about Cellectar's PDC platform and lead product candidate#CLR131: http://bit.ly/30fUIoX#mmsm#BiotechShowcase#JPM20pic.twitter.com/sjWvUDySWrHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
$CLRB Click the following link to see a playback of our presentation at the#BiotechShowcase this afternoon: http://bit.ly/30fUIoX#mmsm#JPM20#JPMHC20pic.twitter.com/wglnvADPyY
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
$CLRB We are excited to be at#BiotechShowcase today with an updated corporate deck. Check it out: http://bit.ly/2QP1TRT#BTS20#JPM20#JPMWeekpic.twitter.com/EDXGZj16tXPrikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
$CLRB Cellectar's CEO Jim Caruso will present TODAY at#BiotechShowcase in Yosemite A at 4:00pm PT. Don’t miss it! (Webcast will be available online after the presentation). http://bit.ly/2PDqGYE#BTS20#JPM20#JPMWeekpic.twitter.com/CwD9UhP8Ju
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.